Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY47.20 CNY
Change Today +1.06 / 2.30%
Volume 15.0M
600161 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

beijing tiantan biological-a (600161) Snapshot

Open
CNY47.50
Previous Close
CNY46.14
Day High
CNY48.30
Day Low
CNY45.01
52 Week High
05/26/15 - CNY53.80
52 Week Low
06/25/14 - CNY17.37
Market Cap
24.3B
Average Volume 10 Days
13.6M
EPS TTM
CNY0.10
Shares Outstanding
515.5M
EX-Date
07/19/12
P/E TM
495.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for BEIJING TIANTAN BIOLOGICAL-A (600161)

Related News

No related news articles were found.

beijing tiantan biological-a (600161) Related Businessweek News

No Related Businessweek News Found

beijing tiantan biological-a (600161) Details

Beijing Tiantan Biological Products Co., Ltd. engages in the research, production, and sale of bacterial and viral vaccines, blood products, diagnostic supplies, and other biological products in China. Its products include hepatitis B vaccine, polio vaccine, MMR vaccine, Japanese encephalitis vaccine, influenza vaccine, varicella vaccine, human serum albumin, intravenous human immunoglobulin, and other species. The company is based in Beijing, China.

beijing tiantan biological-a (600161) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

beijing tiantan biological-a (600161) Key Developments

Beijing Tiantan Biological Products Co., Ltd. Announces Earnings Results for the First Quarter of 2015

Beijing Tiantan Biological Products Co., Ltd. announced earnings results for the first quarter of 2015. For the quarter, the company reported basic earnings per share of CNY 0.02 and weighted average return on net assets of 0.62%.

Beijing Tiantan Biological Products Co., Ltd. to Report Q1, 2015 Results on Apr 25, 2015

Beijing Tiantan Biological Products Co., Ltd. announced that they will report Q1, 2015 results on Apr 25, 2015

Beijing Tiantan Biological Products Co., Ltd. Announces Earnings Results for the Full Year of Fiscal 2014

Beijing Tiantan Biological Products Co., Ltd. announced earnings results for the full year of fiscal 2014. For the year, the company announced basic earnings per share of CNY 0.25 and weighted average return on net assets of 6.84%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600161:CH CNY47.20 CNY +1.06

600161 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hualan Biological Engineering Inc CNY60.72 CNY +0.22
Jiangxi Boya Bio-Pharmaceutical Co Ltd CNY75.46 CNY 0.00
Shanghai RAAS Blood Products Co Ltd CNY65.77 CNY -0.36
View Industry Companies
 

Industry Analysis

600161

Industry Average

Valuation 600161 Industry Range
Price/Earnings 100.0x
Price/Sales 16.6x
Price/Book 14.6x
Price/Cash Flow 532.3x
TEV/Sales 12.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BEIJING TIANTAN BIOLOGICAL-A, please visit www.tiantanbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.